# Stoke Therapeutics Inc. (STOK) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$21M |
| 2024 | -$101M |
| 2023 | -$115M |
| 2022 | -$104M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$53M |
| 2025-09-30 | -$43M |
| 2025-06-30 | -$27M |
| 2025-03-31 | $111M |
| 2024-09-30 | -$30M |
| 2024-06-30 | -$29M |
| 2024-03-31 | -$28M |
| 2023-09-30 | -$27M |
| 2023-06-30 | -$33M |
| 2023-03-31 | -$25M |
| 2022-09-30 | -$27M |
| 2022-06-30 | -$25M |
| 2022-03-31 | -$25M |

Source: [CompaniesByCap](https://companiesbycap.com/company/STOK/operating-income)